|
FY2022
12 months to Dec 31, 2022
|
FY2021
11 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Interest earned on investment held in Trust Account | ||
| Formation and operating costs paid by Promissory note – related party | ||
| Director compensation expense | ||
| Changes in operating assets and liabilities: | ||
| Prepaid assets | ||
| Accrued offering costs and expenses | ||
| Accounts payable and accrued expense | ||
| Due to related parties | ||
| Income tax payable | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash in Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from issuance of shares to initial stockholders | ||
| Proceeds from sale of Founder Shares | ||
| Proceeds from sale of Private Placement units | ||
| Proceeds from issuance of promissory note to related party | ||
| Payment of promissory note to related party | ||
| Payment of deferred offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash, beginning of the period | ||
| Cash – Beginning of period | ||
| Cash – End of period | ||
| Supplemental disclosure of non-cash financing activities: | ||
| Issuance of representative units | ||
| Issuance of representative shares | ||
| Deferred offering costs paid by Sponsor under the promissory note | ||
| Deferred offering costs included in accrued offering costs and expenses | ||
| Remeasurement adjustment charged to additional paid in capital | ||
| Accretion to Common Stock Subject to Redemption |
Loading...
